Metabolism of drugs I. Basic metabolic reactions;Metabolizm leków I. Podstawowe reakcje metaboliczne

Polski Merkuriusz Lekarski

Volumn 18, Issue 106, 2005, Pages 446-452

  Dyderski, Stanisław ^a,c   Grzymisławski, Marian ^b  

^a Kat I Zaklad Farmacji Klinicznej I Biofarmacji Akademii Medycznej Im Karola Marcinkowskiego   (Poland)

^b Katedra I Klinika Gastroenterologii   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Cytochrome P 450; Drug metabolism; Metabolic reactions

Indexed keywords

CYTOCHROME P450; GLUTAMINE; GLYCINE; HYDROCHLORIC ACID; INTESTINE ENZYME; MICROSOME ENZYME; XENOBIOTIC AGENT;

AEROBIC METABOLISM; DIGESTIVE SYSTEM; DRUG ACETYLATION; DRUG HYDROLYSIS; DRUG INACTIVATION; DRUG METABOLISM; DRUG TRANSFORMATION; INTESTINE FLORA; LIPOPHILICITY; LIVER METABOLISM; METHYLATION; REVIEW; STOMACH;

CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYDROLYSIS; LIVER; OXIDATION-REDUCTION; PHARMACEUTICAL PREPARATIONS;

EID: 18544370211     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Cummings J.H., Englyst H.N.: Fermentation in the human large intestine: Evidence and implications for health. Lancet, 1983, 43, 35-44.
2. Daly A.K., Cholerton S., Gregory W., Idle J.: Metabolic polymorphisms. Pharmac. Ther., 1993, 57, 129-160.
3. De Morais S.M.F., Uetrecht J.P., Wells P.G.: Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's Syndrome. Gastroenterology, 1992, 102, 577-586.
4. Goldstein J.A.: Invited review: Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br. J. Clin. Pharm., 2001, 52, 349-355.
5. Kall M.A., Clausen J.: Dietary effect of mixed function P450 1A2 activity assayed by estimation of caffeine metabolism in man. Human Experimental Toxicology 1995, 14, 801-807.
6. Koch R.L., Chrystal E.J.T., Beaulieu B.B. Jr, Goldman P.: Acetamide: A metabolite of metronidazole formed by the intestinal flora. Biochem. Pharmacol., 1979, 28, 3611-3615.
7. Koch R.L., Goldman P.: The anaerobic metabolism of metronidazole from N-(2-hydroxyethyl)-oxamic acid. J. Pharmacol. Exp. Ther., 1979, 208, 406-410.
8. Lee C.R., Goldstein J.A., Pieper L.: Invited review: Cytochrome P-450 2C9 genetic polymorphisms: A comprehensive review of the in vitro and human data. Pharmacogenetics, 2002, 12, 251-263.
9. Levy G.: Sulfate conjugation in drug metabolism: role of inorganic sulfate. Fed. Proceed., 1986, 45/8, 2235-2240.
10. Lin J.H., Chiba M., Chen I.W., Nishime J.A., Vastag K.J.: Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence. Drug Metab. Dispos., 1996, 24, 1298-1306.
11. McKinnon R.A., McManus M.E.: Localization of Cytochromes P-450 in human tissues: Implications for chemical toxicity. Pathology, 1996, 28, 148-155.
12. Mitsuoska T.: Intestinal flora and aging. Nutr. Rev., 1992, 50, 438-446.
13. Mugford C.A., Kedderis G. L.: Sex-Dependent Metabolism of Xenobiotics. Drug Met. Rev., 1998, 30, 441-498.
14. Mulder G. J.: Sex differences in drug conjugation and their consequences for drug toxicity. Sulfation, glucuronidation and glutathione conjugation. Chem. Biol. Interactions, 1986, 57, 1-15.
15. Murray M., Reidy G.F.: Selectivity in the inhibition of mammalian Cytochromes P-450 by chemical agents. Pharmacological Reviews, 1990, 42/ 2, 85-101.
16. Park B.K., Kitteringham N.R., Pirmohamed M., Tucker G.T.: Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications. Br. J. Clin. Pharmacol., 1996, 41, 477-491.
17. Philips K.A., Veenstra D.L., Oren E., Lee J.K., Sadee W.: Potential role of pharmacogenomics in reducing adverse drug reactions. A systematic review. JAMA, 2001, 286, 18, 2270-2279.
18. Romkes M., Faletto M.B., Blaisdell J.A., Raucy J.L., Goldstein J.A.: Cloning and expression of complementary DNAs for multiple members of the human cytochrome P-450IIC subfamily. Biochemistry, 1991, 30, 3247-3255.
19. Scheline R.R.: Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol. Rev., 1973, 25, 451-523.
20. Spatzenegger M., Jaeger W.: Clinical importance of hepatic cytochrome P-450 in drug metabolism. Drug Metab. Rev., 1995, 27, 397-417.
21. Temellini A,, Mogavero S., Giulianotti P.C., Pietrabissa A., Mosca F., Pacifici G.: Conjugation of benzole acid with glycine in human liver and kidney: a study on the interindividual variability. Xenobiotica, 1993, 23/12, 1427-1433.
22. Weinshilboum R.: Inheritance and drug response. N. Engl. J. Med., 2003, 348, 6, 529-537.
23. Vesell E.S.: Pharmacogenetics: Multiple interactions between genes and environment as determinants of drug response. Am. J. Med., 1979, 66, 183-187.
24. Walter-Sack I., Klotz U.: Influence of diet and nutritional status on drug metabolism. Clin. Pharmacokinet., 1996, 31(1), 47-64.